Variation in chromogranin A serum levels during intermittent versus continuous androgen deprivation therapy for prostate adenocarcinoma.
- Published in:
- Prostate, 2003, v. 55, n. 3, p. 168, doi. 10.1002/pros.10222
- By:
- Publication type:
- Article
Works matching IS 02704137 AND DT 2003 AND VI 55 AND IP 3
Results: 8
1
2
Growth inhibition and differentiation in human prostate carcinoma cells induced by the vitamin D analog 1α,24-dihydroxyvitamin D<sub>2</sub>.
- Published in:
- Prostate, 2003, v. 55, n. 3, p. 159, doi. 10.1002/pros.10219
- By:
- Publication type:
- Article
3
Pathobiology of autochthonous prostate cancer in a pre-clinical transgenic mouse model.
- Published in:
- Prostate, 2003, v. 55, n. 3, p. 219, doi. 10.1002/pros.10215
- By:
- Publication type:
- Article
4
Intraepithelial and stromal lymphocytes in the normal human prostate.
- Published in:
- Prostate, 2003, v. 55, n. 3, p. 187, doi. 10.1002/pros.10224
- By:
- Publication type:
- Article
5
Intermediate basal cells of the prostate: In vitro and in vivo characterization (Levi A. Garraway and Douglas Lin contributed equally to this work.).
- Published in:
- Prostate, 2003, v. 55, n. 3, p. 206, doi. 10.1002/pros.10244
- By:
- Publication type:
- Article
6
Expression of ERα and ERβ in prostate cancer.
- Published in:
- Prostate, 2003, v. 55, n. 3, p. 180, doi. 10.1002/pros.10242
- By:
- Publication type:
- Article
7
Hypermethylation of GSTP1, CD44, and E-cadherin genes in prostate cancer among US Blacks and Whites.
- Published in:
- Prostate, 2003, v. 55, n. 3, p. 199, doi. 10.1002/pros.10236
- By:
- Publication type:
- Article
8
Reduced circulating androgen bioactivity in patients with prostate cancer (Taneli Raivio and Henrikki Santti contributed equally to this work.).
- Published in:
- Prostate, 2003, v. 55, n. 3, p. 194, doi. 10.1002/pros.10234
- By:
- Publication type:
- Article